These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23961642)

  • 1. [Still far too many persons become infected also in Germany with HIV (interview by Peter Leiner)].
    Brodt HR
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():8-9. PubMed ID: 23961642
    [No Abstract]   [Full Text] [Related]  

  • 2. Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?
    Nellen JF; Nieuwkerk PT; Burger DM; Wibaut M; Gras LA; Prins JM
    AIDS Care; 2009 Jul; 21(7):842-50. PubMed ID: 20024740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV infection in women].
    Haberl A
    MMW Fortschr Med; 2009 Apr; 151(18):45-6, 48. PubMed ID: 19769075
    [No Abstract]   [Full Text] [Related]  

  • 4. [This far it can go without HIV therapy!].
    Bogner JR; Steinert D; Coppenrath E
    MMW Fortschr Med; 2016 Jun; 158 Suppl 1():7. PubMed ID: 27259886
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to antiretroviral therapy in an urban, free-care HIV clinic in Guatemala City, Guatemala.
    Campbell JI; Ruano AL; Samayoa B; Estrado Muy DL; Arathoon E; Young B
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(6):390-5. PubMed ID: 21075914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Let's not forget the Third World.
    Rhame F
    Minn Med; 2009 Oct; 92(10):38-9. PubMed ID: 19916272
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse.
    Harding R; Lampe FC; Norwood S; Date HL; Clucas C; Fisher M; Johnson M; Edwards S; Anderson J; Sherr L
    Sex Transm Infect; 2010 Dec; 86(7):520-4. PubMed ID: 20551235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV testing and HIV/AIDS treatment services in rural counties in 10 southern states: service provider perspectives.
    Sutton M; Anthony MN; Vila C; McLellan-Lemal E; Weidle PJ
    J Rural Health; 2010; 26(3):240-7. PubMed ID: 20633092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychosocial aspects on the treatment of HIV-infection].
    Battegay M; Haerry DH; Fehr J; Staehelin C; Wandeler G; Elzi L
    Ther Umsch; 2014 Aug; 71(8):509-13. PubMed ID: 25093317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS profile and realities at a regional antiretroviral therapy clinic in Jerusalem: 12 years analysis.
    Elinav H; Pops KO; Shasha D; Korem M; Hauzi-Bashan M; Grossman Z; Maayan S
    Scand J Infect Dis; 2012 Jan; 44(1):65-9. PubMed ID: 21923627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral adherence among rural compared to urban veterans with HIV infection in the United States.
    Ohl ME; Perencevich E; McInnes DK; Kim N; Rimland D; Akgun K; Fiellin DA; Skanderson M; Wang K; Justice A
    AIDS Behav; 2013 Jan; 17(1):174-80. PubMed ID: 23080359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.
    Pujades-Rodríguez M; Schramm B; Som L; Nerrienet E; Narom P; Chanchhaya N; Ferradini L; Balkan S
    Trop Med Int Health; 2011 Feb; 16(2):205-13. PubMed ID: 21087376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.
    Leigh Brown AJ; Frost SD; Mathews WC; Dawson K; Hellmann NS; Daar ES; Richman DD; Little SJ
    J Infect Dis; 2003 Feb; 187(4):683-6. PubMed ID: 12599087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
    Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
    Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measure of effectiveness and adherence to antiretroviral therapy in HIV-infected patients in Cameroon].
    Mahy S; Duong M; Huraux JM; Aurenche C; Ndong JG; Birguel J; Piroth L; Chavanet P
    Med Mal Infect; 2011 Apr; 41(4):176-80. PubMed ID: 20650582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda.
    Senkomago V; Guwatudde D; Breda M; Khoshnood K
    AIDS Care; 2011 Oct; 23(10):1246-53. PubMed ID: 21939403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equity in the use of antiretroviral treatment in the public health care system in urban South Africa.
    Cleary S; Silal S; Birch S; Carrara H; Pillay-van Wyk V; Rehle T; Schneider H
    Health Policy; 2011 Mar; 99(3):261-6. PubMed ID: 21075470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
    Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
    HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nested model reveals potential amplification of an HIV epidemic due to drug resistance.
    Saenz RA; Bonhoeffer S
    Epidemics; 2013 Mar; 5(1):34-43. PubMed ID: 23438429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance found in SE area, representing poor, rural population. Resistance screening is indicated.
    AIDS Alert; 2005 Dec; 20(12):140-1. PubMed ID: 16397941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.